Filtered By:
Condition: Hemorrhagic Stroke
Drug: Cilostazol
Management: National Institutes of Health (NIH)
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 2 results found since Jan 2013.
Cilostazol is Effective to Prevent Stroke-Associated Pneumonia in Patients Receiving Tube Feeding
AbstractStroke-associated pneumonia (SAP) is a frequent complication in acute ischemic stroke (IS) patients, especially those receiving tube feeding (TF). In this retrospective study, we investigated whether or not cilostazol, a pluripotent phosphodiesterase III-specific inhibitor with anti-platelet and vasculogenic effects, can prevent SAP in these patients and reduce their duration of stay in intensive care unit/hospitalization. We recruited 158 IS patients receiving TF. Patients ’ characteristics (including age, gender, past history), National Institute of Health Stroke Scale and serum albumin level on admission, conc...
Source: Dysphagia - April 21, 2018 Category: Speech-Language Pathology Source Type: research
